Matthew Quick, MD
Hospitalist · Jonesboro, ARNPI 1376739854
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 25 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by GSK at 25.8% of the total. Reporting peaked in 2019 at $104 and has fallen 78.4% since, to $23 in 2025.
Across 25 payments — averaging $16.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$108
- Pfizer$68
- Novartis$54
- Boehringer Ingelheim$44
- Merck$33
- AstraZeneca$29
- plus $82 from 5 others
What the payments were for
- Food & beverage$418100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 6 | $108 |
| Pfizer | 5 | $68 |
| Novartis | 3 | $54 |
| Boehringer Ingelheim | 2 | $44 |
| Merck | 2 | $33 |
| AstraZeneca(2 entities) | 2 | $29 |
| Scpharmaceuticals Inc. | 1 | $24 |
| Johnson & Johnson | 1 | $18 |
| Collegium Pharmaceutical, Inc. | 1 | $15 |
| AbbVie | 1 | $13 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $12 |
How this compares
$418 in reported general payments places this provider in the 85th percentile of 125 hospitalist providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 291 | $91,585 |
| JanuviaSitagliptin Phosphate | 109 | $32,530 |
| EntrestoSacubitril/Valsartan | 67 | $27,216 |
| XareltoRivaroxaban | 62 | $19,733 |
| JardianceEmpagliflozin | 59 | $19,443 |
| RybelsusSemaglutide | 18 | $18,546 |
| BrilintaTicagrelor | 77 | $17,680 |
| Cinacalcet Hcl | 12 | $12,639 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 22 | $11,305 |
| GlyxambiEmpagliflozin/Linagliptin | 26 | $7,928 |
| Atorvastatin Calcium | 513 | $7,062 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 13 | $6,535 |
| Bevespi AerosphereGlycopyrrolate/Formoterol Fum | 13 | $6,063 |
| Potassium Chloride | 236 | $5,799 |
| FarxigaDapagliflozin Propanediol | 13 | $5,530 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $68 | $91,585291 claims |
| Boehringer IngelheimJardiance, Combivent Respimat, Glyxambi, Stiolto Respimat, Tradjenta | $44 | $50,260134 claims |
| MerckJanuvia | $33 | $32,530109 claims |
| AstraZenecaBrilinta, Bevespi Aerosphere, Farxiga, Symbicort | $29 | $32,159114 claims |
| NovartisEntresto | $54 | $27,21667 claims |
| Johnson & JohnsonXarelto | $18 | $19,73362 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 125 hospitalist providers in Arkansas.
Other hospitalist in Jonesboro
- Jonathan HoltJonesboro$1K
- Jeffery CopelandJonesboro$863
- Aaron WintersternJonesboro$508
- Brock HarrisJonesboro$338
- Abhijit ShivkumarJonesboro$319
- Wanda WilliamsJonesboro$260
- Duc VoJonesboro$259
- Taylor AllowayJonesboro$224
- Kirollos GabrahJonesboro$184
- Alexander NavarroHot Springs$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.